Hemoglobinopathy & Thalassemia Screening
Inherited hemoglobin disorders are among the most prevalent genetic conditions worldwide, affecting over 7% of the global population. Effective prevention and management depend critically on high-resolution laboratory screening.
Aucien's specialized HPLC solutions provide precise quantitation of HbA2 and HbF levels while displaying distinct elution profiles for abnormal hemoglobin variants, enabling definitive pre-marital and antenatal screening.
Key Clinical & Operational Benefits
• Precise HbA2 cutoff determination for Beta-Thalassemia trait identification
• Comprehensive variant identification library
• Fully automated sample barcode tracking and LIS integration
Diagnostic & Clinical Indications
• Antenatal and pre-conceptional genetic risk counseling
• Differential diagnosis of microcytic hypochromic anemias
• Detection of sickle cell trait (HbS) and hemoglobin E disease
Associated Laboratory Analyzers
HLC-723 G11 ß-Thalassaemia Analysis Mode
Dedicated HPLC solution for the quantitative determination of HbA2, HbF and screening of structural hemoglobinopathies (HbS, HbC, HbD, HbE).
HLC-723 G8 ß-Thalassaemia Analysis Mode
Proven laboratory instrument for hemoglobinopathy screening with automated sample identification and robust column chemistry.
Request Clinical Solution Consultation
Inquire about testing workflows, instrument throughput, and implementation support for this solution.
Other Solutions
Diabetes Care & HbA1c Monitoring Solutions
Standardized, precise, and variant-resilient HPLC solutions for diabetes screening, diagnostic confirmation, and long-term glycemic monitoring.
Point-of-Care & Critical Immunoassay Diagnostics
Rapid, unit-dose automated immunoassay testing delivering critical biomarker results within 20 minutes for emergency departments and hospital labs.